Daniel Vilató is a native of New York City whose Genentech career started at Roche in Nutley, NJ in 2007 after completing his MBA in Finance at Rutgers Business School. In his current role on the Biomarker Testing and Personalized Healthcare (PHC) Oncology Team, he works collaboratively with health systems and multidisciplinary cancer teams to tackle diagnostic and PHC challenges to enable patients' access to optimal treatment and clinical trials. Daniel has held previous roles in oncology marketing, forecasting, and account management, and is currently a leader in Genentech's Latinx/Hispanic employee resource group, VIDA.